Novel metal-organic nanoplatform enhances cancer treatment through combined chemo and photodynamic therapy, indicating its potential effectiveness.
Antitumor efficacy based on conventional chemodynamic therapy (CDT) is frequently constrained by insufficient endogenous H 2 O 2 and the limitations of monotherapy. Herein, we developed a metal‐organic nanoplatform (CA‐Fe NPs). This platform was fabricated through Fe 3+ ‐driven coordination assembly of artesunate (AS) and chlorin e6 (Ce6), facilitating preferential tumor accumulation via the enhanced permeability and retention (EPR) effect. Upon cellular internalization and 660 nm laser irradiation, the nanodrug enables a synergistic combination of Ce6‐mediated photodynamic therapy (PDT) and AS‐induced oxidative stress, which collaboratively amplifies intracellular reactive oxygen species (ROS) generation. This cascade induces mitochondrial membrane potential collapse, leading to extensive apoptotic cell death (77.5%). In a 4T1 tumor‐bearing mouse model, this approach achieved marked tumor suppression with an excellent safety profile, offering a promising strategy for combination therapy.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: